1887
2 - Qatar Health 2021 Conference abstracts
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Diabetic patients are at significant risk of serious complications and higher mortality rates if they contract COVID-191,2,3. Primary Health Care Corporation (PHCC) in Qatar launched a Diabetes Teleconsultation Clinic to proactively support high risk diabetic patients with a hemoglobin A1c (HbA1C) superior or equal to 8 mg/dL and without a primary health care encounter in the last 2-12 months, in an attempt to support this high risk population and still provide continuity of care. Patients meeting the criteria were proactively contacted and received a teleconsultation call from a family medicine physician. During the call, family physicians and patients reviewed individual management plans, and if agreed and required changes, the patient management plans were adjusted and monitored. Patients were additionally supported by a wider team of professionals via teleconsultations, including dieticians, health educators and primary care psychology and psychiatry services. A paired sample T-Test (Table 1) was conducted to compare the HbA1c mean levels for patients before and after joining the PHCC Diabetes Management Teleconsultation Clinic, after a 4-month period. There was a statistically significant difference in the results of mean HbA1c levels for patients before joining the Diabetes Management Teleconsultation Clinic and after the intervention. Of the 384 patients analysed, the average HbA1c level before the intervention was 9.49 mg/dL, and after the intervention the average was 8.83 mg/dL (p < 0.001). The use of teleconsultations, remote multidisciplinary team support, and collaborative patient management plans has had a positive impact on the health outcomes of 384 high-risk diabetic patients within primary care. This inclusive model of care will be replicated to support more patients as a preventative and supportive intervention not only during the COVID-19 pandemic but in the long term.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2021.qhc.2
2021-08-10
2021-09-20
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2021/2/jemtac.2021.qhc.2.html?itemId=/content/journals/10.5339/jemtac.2021.qhc.2&mimeType=html&fmt=ahah

References

  1. Apicella M, Campopiano M, Mantuano M, Mazoni L, Coppelli A, Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The Lancet Diabetes and Endocrinology. 2020; 8:(9):782–792.
    [Google Scholar]
  2. Quinn LM, Davies MJ, Hadjiconstantinou M. Virtual Consultations and the Role of Technology During the COVID-19 Pandemic for People With Type 2 Diabetes: The UK Perspective. J Med Internet Res. 2020; 22:(8):e21609.
    [Google Scholar]
  3. Jones MS, Goley AL, Alexander BE, Keller SB, Caldwell MM, Buse JB. Inpatient transition to Virtual Care During COVID-19 Pandemic. Diabetes Technol Ther. 2020; 22: (6):445–448.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2021.qhc.2
Loading
/content/journals/10.5339/jemtac.2021.qhc.2
Loading

Data & Media loading...

  • Article Type: Conference Abstract
Keyword(s): COVID-19 , diabetes , diabetes type 2 , primary health care and teleconsultations
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error